Luciano Costa
MD, PhD
Professor of Medicine
👥Biography 个人简介
Luciano Costa at UAB contributed to the clinical development of talquetamab (GPRC5D x CD3), a bispecific targeting the novel myeloma antigen GPRC5D. His work on the MonumenTAL trial demonstrated meaningful activity of talquetamab in heavily pre-treated myeloma, including patients refractory to BCMA-targeted therapies. He has investigated combination strategies using GPRC5D-targeting bispecifics with other myeloma agents. His research addresses sequencing bispecific antibodies and understanding GPRC5D antigen expression biology in myeloma.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Luciano Costa 的研究动态
Follow Luciano Costa's research updates
留下邮箱，当我们发布与 Luciano Costa（University of Alabama at Birmingham）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment